Artificial intelligence for drug discovery.

San Francisco, United States

Artificial Intelligence


Atomwise uses artificial intelligence to help discover new medicines. Its groundbreaking AtomNet technology reasons like a human medicinal chemist, using powerful Deep Learning algorithms and supercomputers to analyze millions of potential treatments each day. Atomwise has launched 27 drug discovery projects with innovative organizations, including Merck and Harvard, advancing research in diseases as diverse as Ebola, multiple sclerosis, and leukemia. Now, through it's many partnering programs, Atomwise is actively seeking new drug discovery collaborators to address the health challenges of our time with the power of artificial intelligence.